188 related articles for article (PubMed ID: 34218540)
1. The prevalence and the impact of sarcopenia in digestive cancers. A systematic review.
Haiducu C; Buzea A; Mirea LE; Dan GA
Rom J Intern Med; 2021 Dec; 59(4):328-344. PubMed ID: 34218540
[No Abstract] [Full Text] [Related]
2. Sarcopenia as a predictor of poor surgical and oncologic outcomes after abdominal surgery for digestive tract cancer: A prospective cohort study.
Zhang S; Tan S; Jiang Y; Xi Q; Meng Q; Zhuang Q; Han Y; Sui X; Wu G
Clin Nutr; 2019 Dec; 38(6):2881-2888. PubMed ID: 30630709
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Sarcopenia and Its Relationship with Nutritional State and Quality of Life in Patients with Digestive Diseases.
Onishi S; Shiraki M; Nishimura K; Hanai T; Moriwaki H; Shimizu M
J Nutr Sci Vitaminol (Tokyo); 2018; 64(6):445-453. PubMed ID: 30606967
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn's disease.
Grillot J; D'Engremont C; Parmentier AL; Lakkis Z; Piton G; Cazaux D; Gay C; De Billy M; Koch S; Borot S; Vuitton L
Clin Nutr; 2020 Oct; 39(10):3024-3030. PubMed ID: 31980183
[TBL] [Abstract][Full Text] [Related]
5. Computed Tomography-Assessed Skeletal Muscle Mass as a Predictor of Outcomes in Lung Cancer Surgery.
Nishimura JM; Ansari AZ; D'Souza DM; Moffatt-Bruce SD; Merritt RE; Kneuertz PJ
Ann Thorac Surg; 2019 Nov; 108(5):1555-1564. PubMed ID: 31228408
[TBL] [Abstract][Full Text] [Related]
6. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer.
Griffin OM; Duggan SN; Ryan R; McDermott R; Geoghegan J; Conlon KC
Pancreatology; 2019 Sep; 19(6):850-857. PubMed ID: 31362865
[TBL] [Abstract][Full Text] [Related]
7. Correlation between muscle mass and handgrip strength in digestive cancer patients undergoing chemotherapy.
Moreau J; Ordan MA; Barbe C; Mazza C; Perrier M; Botsen D; Brasseur M; Portefaix C; Renard Y; Tallière B; Bertin E; Hoeffel C; Bouché O
Cancer Med; 2019 Jul; 8(8):3677-3684. PubMed ID: 31115188
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer.
Huang DD; Wang SL; Zhuang CL; Zheng BS; Lu JX; Chen FF; Zhou CJ; Shen X; Yu Z
Colorectal Dis; 2015 Nov; 17(11):O256-64. PubMed ID: 26194849
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies.
Levolger S; van Vugt JL; de Bruin RW; IJzermans JN
Br J Surg; 2015 Nov; 102(12):1448-58. PubMed ID: 26375617
[TBL] [Abstract][Full Text] [Related]
11. The impact of computed tomography-assessed sarcopenia on outcomes for trauma patients - a systematic review and meta-analysis.
Xia W; Barazanchi AWH; MacFater WS; Hill AG
Injury; 2019 Sep; 50(9):1565-1576. PubMed ID: 31280971
[TBL] [Abstract][Full Text] [Related]
12. Preoperative evaluation of sarcopenia in patients with colorectal cancer: a prospective study.
Nunes GD; Cardenas LZ; Miola TM; Souza JO; Carniatto LN; Bitencourt AGV
Rev Assoc Med Bras (1992); 2023; 69(2):222-227. PubMed ID: 36790231
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes.
Tegels JJ; van Vugt JL; Reisinger KW; Hulsewé KW; Hoofwijk AG; Derikx JP; Stoot JH
J Surg Oncol; 2015 Sep; 112(4):403-7. PubMed ID: 26331988
[TBL] [Abstract][Full Text] [Related]
14. Computed Tomography-Assessed Sarcopenia Indexes Predict Major Complications following Surgery for Hepatopancreatobiliary Malignancy: A Meta-Analysis.
Cao Q; Xiong Y; Zhong Z; Ye Q
Ann Nutr Metab; 2019; 74(1):24-34. PubMed ID: 30513518
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of sarcopenia in older patients with colorectal cancer.
Broughman JR; Williams GR; Deal AM; Yu H; Nyrop KA; Alston SM; Gordon BB; Sanoff HK; Muss HB
J Geriatr Oncol; 2015 Nov; 6(6):442-5. PubMed ID: 26365898
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia, as Assessed by Psoas Cross-Sectional Area, Is Predictive of Adverse Postoperative Outcomes in Patients Undergoing Colorectal Cancer Surgery.
Richards SJG; Senadeera SC; Frizelle FA
Dis Colon Rectum; 2020 Jun; 63(6):807-815. PubMed ID: 32149784
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia is Associated with Perioperative Outcomes in Gastric Cancer Patients Undergoing Gastrectomy.
Shi B; Liu S; Chen J; Liu J; Luo Y; Long L; Lan Q; Zhang Y
Ann Nutr Metab; 2019; 75(4):213-222. PubMed ID: 31846973
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia in Chronic Liver Disease: Impact on Outcomes.
Ooi PH; Hager A; Mazurak VC; Dajani K; Bhargava R; Gilmour SM; Mager DR
Liver Transpl; 2019 Sep; 25(9):1422-1438. PubMed ID: 31242345
[TBL] [Abstract][Full Text] [Related]
19. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of preoperative low bone mineral density in patients with digestive cancers: a systematic review and meta-analysis.
Watanabe J; Saitsu A; Miki A; Kotani K; Sata N
Arch Osteoporos; 2022 Feb; 17(1):33. PubMed ID: 35149903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
